Capitolis Advisors LLC Pfizer Inc Transaction History

Capitolis Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $23.6 Million - $27.9 Million	-506,602 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $39.9 Million - $49.5 Million	-872,636 Reduced 63.27%	506,602 $26.2 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $2.93 Million - $4.34 Million	70,893 Added 5.42%	1,379,238 $81.4 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $538,078 - $691,207	-13,709 Reduced 1.04%	1,308,345 $54.1 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $16.9 Million - $19.1 Million	470,639 Added 55.28%	1,322,054 $51.8 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $17 Million - $19.2 Million	507,357 Added 147.46%	851,415 $30.8 Million
Q4 2020 May 07, 2021	BUY	$33.47 - $42.56 $11.5 Million - $14.6 Million	344,058 New	344,058 $12.7 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Advisors LLC with notifications on news.